{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:18:58Z","timestamp":1758892738090,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["81460075"],"award-info":[{"award-number":["81460075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10554-020-02103-0","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T20:02:31Z","timestamp":1606507351000},"page":"1203-1213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of spectral tracking technique to evaluate the changes in left ventricular function in patients undergoing chemotherapy for colorectal cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Zhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuican","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,27]]},"reference":[{"issue":"10207","key":"2103_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet (London, England) 394(10207):1467\u20131480. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0","journal-title":"Lancet (London, England)"},{"issue":"4","key":"2103_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.21457","volume":"68","author":"AMD Wolf","year":"2018","unstructured":"Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin 68(4):250\u2013281. https:\/\/doi.org\/10.3322\/caac.21457","journal-title":"CA: Cancer J Clin"},{"issue":"1","key":"2103_CR3","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.clcc.2018.10.002","volume":"18","author":"PM Kasi","year":"2019","unstructured":"Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18(1):e87\u2013e95. https:\/\/doi.org\/10.1016\/j.clcc.2018.10.002","journal-title":"Clin Colorectal Cancer"},{"issue":"19","key":"2103_CR4","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/jco.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J ClinOncol 27(19):3109\u20133116. https:\/\/doi.org\/10.1200\/jco.2008.20.6771","journal-title":"J ClinOncol"},{"issue":"4","key":"2103_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytz146","volume":"3","author":"G Joy","year":"2019","unstructured":"Joy G, Eissa H, Al Karoudi R, White SK (2019) Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features. Eur Heart J Case Rep 3(4):1\u20136. https:\/\/doi.org\/10.1093\/ehjcr\/ytz146","journal-title":"Eur Heart J Case Rep"},{"issue":"5","key":"2103_CR6","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.21037\/jgo.2019.07.04","volume":"10","author":"JM Redman","year":"2019","unstructured":"Redman JM, Rhea LP, Brofferio A, Whelpley M, Gulley JL, Gatti-Mays ME, McMahon S, Cordes LM, Strauss J (2019) Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion. J GastrointestOncol 10(5):1010\u20131014. https:\/\/doi.org\/10.21037\/jgo.2019.07.04","journal-title":"J GastrointestOncol"},{"issue":"4","key":"2103_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/0284186x.2019.1711164","volume":"59","author":"A Dyhl-Polk","year":"2020","unstructured":"Dyhl-Polk A, Vaage-Nilsen M, Schou M, Vistisen KK, Lund CM, K\u00fcmler T, Appel JM, Nielsen DL (2020) Incidence and risk markers of 5-fluorouracil and capecitabinecardiotoxicity in patients with colorectal cancer. ActaOncol (Stockholm, Sweden) 59(4):475\u2013483. https:\/\/doi.org\/10.1080\/0284186x.2019.1711164","journal-title":"ActaOncol (Stockholm, Sweden)"},{"issue":"10","key":"2103_CR8","doi-asserted-by":"publisher","first-page":"e012798","DOI":"10.1136\/bmjopen-2016-012798","volume":"6","author":"A Polk","year":"2016","unstructured":"Polk A, Shahmarvand N, Vistisen K, Vaage-Nilsen M, Larsen FO, Schou M, Nielsen DL (2016) Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer. BMJ Open 6(10):e012798. https:\/\/doi.org\/10.1136\/bmjopen-2016-012798","journal-title":"BMJ Open"},{"issue":"6","key":"2103_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/030089168206800609","volume":"68","author":"R Labianca","year":"1982","unstructured":"Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G (1982) Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 68(6):505\u2013510","journal-title":"Tumori"},{"issue":"4","key":"2103_CR10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/j.1875-9114.1997.tb03748.x","volume":"17","author":"CC Meyer","year":"1997","unstructured":"Meyer CC, Calis KA, Burke LB, Walawander CA, Grasela TH (1997) Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 17(4):729\u2013736","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2103_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jemermed.2015.09.001","volume":"50","author":"JC Ray","year":"2016","unstructured":"Ray JC, Cho P, Dragon M, Graham CG (2016) A case of 5-fluorouracil-induced cardiac arrest. J Emerg Med 50(1):e1-6. https:\/\/doi.org\/10.1016\/j.jemermed.2015.09.001","journal-title":"J Emerg Med"},{"issue":"8","key":"2103_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11936-019-0740-5","volume":"21","author":"JP McDonald","year":"2019","unstructured":"McDonald JP, MacNamara JP, Zaha VG (2019) Challenges in implementing optimal echocardiographic screening in cardio-oncology. Curr Treat Options Cardiovasc Med 21(8):39. https:\/\/doi.org\/10.1007\/s11936-019-0740-5","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"8","key":"2103_CR13","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1111\/echo.14427","volume":"36","author":"J He","year":"2019","unstructured":"He J, Yang L (2019) Value of three-dimensional speckle-tracking imaging in detecting left ventricular systolic function in patients with dilated cardiomyopathy. Echocardiography (Mount Kisco, NY) 36(8):1492\u20131495. https:\/\/doi.org\/10.1111\/echo.14427","journal-title":"Echocardiography (Mount Kisco, NY)"},{"issue":"1","key":"2103_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.echo.2011.10.009","volume":"25","author":"P Reant","year":"2012","unstructured":"Reant P, Barbot L, Touche C, Dijos M, Arsac F, Pillois X, Landelle M, Roudaut R, Lafitte S (2012) Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am SocEchocardiogr 25(1):68\u201379. https:\/\/doi.org\/10.1016\/j.echo.2011.10.009","journal-title":"J Am SocEchocardiogr"},{"issue":"8","key":"2103_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1139\/cjpp-2012-0398","volume":"91","author":"C Morno\u015f","year":"2013","unstructured":"Morno\u015f C, Petrescu L (2013) Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J PhysiolPharmacol 91(8):601\u2013607. https:\/\/doi.org\/10.1139\/cjpp-2012-0398","journal-title":"Can J PhysiolPharmacol"},{"issue":"4","key":"2103_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11864-020-0719-1","volume":"21","author":"T Shiga","year":"2020","unstructured":"Shiga T, Hiraide M (2020) Cardiotoxicities of 5-fluorouracil and other fluoropyrimidines. Curr Treat Options Oncol 21(4):27. https:\/\/doi.org\/10.1007\/s11864-020-0719-1","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"2103_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/annonc\/mdh150","volume":"15","author":"T S\u00fcdhoff","year":"2004","unstructured":"S\u00fcdhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U, Schmiegel W (2004) 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 15(4):661\u2013664. https:\/\/doi.org\/10.1093\/annonc\/mdh150","journal-title":"Ann Oncol"},{"issue":"1","key":"2103_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00280-011-1669-x","volume":"69","author":"SA Jensen","year":"2012","unstructured":"Jensen SA, S\u00f8rensen JB (2012) 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer ChemotherPharmacol 69(1):57\u201364. https:\/\/doi.org\/10.1007\/s00280-011-1669-x","journal-title":"Cancer ChemotherPharmacol"},{"issue":"8","key":"2103_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","volume":"39","author":"A Polk","year":"2013","unstructured":"Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL (2013) Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev 39(8):974\u2013984. https:\/\/doi.org\/10.1016\/j.ctrv.2013.03.005","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2103_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00280-019-03888-1","volume":"84","author":"X Jin","year":"2019","unstructured":"Jin X, Bai Y, Gao L, Wu S (2019) Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients. Cancer ChemotherPharmacol 84(3):599\u2013607. https:\/\/doi.org\/10.1007\/s00280-019-03888-1","journal-title":"Cancer ChemotherPharmacol"},{"issue":"5","key":"2103_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/annonc\/mdu055","volume":"25","author":"C Lestuzzi","year":"2014","unstructured":"Lestuzzi C, Vaccher E, Talamini R, Lleshi A, Meneguzzo N, Viel E, Scalone S, Tartuferi L, Buonadonna A, Ejiofor L, Schmoll HJ (2014) Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk. Ann Oncol 25(5):1059\u20131064. https:\/\/doi.org\/10.1093\/annonc\/mdu055","journal-title":"Ann Oncol"},{"issue":"6","key":"2103_CR22","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12012-019-09523-y","volume":"19","author":"C Bergamini","year":"2019","unstructured":"Bergamini C, Dolci G, Truong S, Zanolla L, Benfari G, Fiorio E, Rossi A, Ribichini FL (2019) Role of speckle tracking echocardiography in the evaluation of breast cancer patients undergoing chemotherapy: review and meta-analysis of the literature. CardiovascToxicol 19(6):485\u2013492. https:\/\/doi.org\/10.1007\/s12012-019-09523-y","journal-title":"CardiovascToxicol"},{"issue":"1","key":"2103_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/mph.0000000000000683","volume":"39","author":"K Yanagimoto","year":"2017","unstructured":"Yanagimoto K, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y (2017) Decrease of cardiac base rotation in 2D speckle tracking indicates drug-induced cardiomyopathy after chemotherapy in children with cancer. J PediatrHematolOncol 39(1):10\u201314. https:\/\/doi.org\/10.1097\/mph.0000000000000683","journal-title":"J PediatrHematolOncol"},{"issue":"1","key":"2103_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/cdt.2017.06.01","volume":"8","author":"D Muraru","year":"2018","unstructured":"Muraru D, Niero A, Rodriguez-Zanella H, Cherata D, Badano L (2018) Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. CardiovascDiagnTher 8(1):101\u2013117. https:\/\/doi.org\/10.21037\/cdt.2017.06.01","journal-title":"CardiovascDiagnTher"},{"issue":"6","key":"2103_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00392-019-01556-1","volume":"109","author":"M Coutinho Cruz","year":"2020","unstructured":"Coutinho Cruz M, MouraBranco L, Portugal G, Galrinho A, Tim\u00f3teo AT, Rio P, Ilh\u00e3o Moreira R, Mendon\u00e7a T, Leal A, Gameiro F, Duarte Oliveira S, Luz R, Cruz Ferreira R (2020) Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. Clin Res Cardiol 109(6):673\u2013684. https:\/\/doi.org\/10.1007\/s00392-019-01556-1","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"2103_CR26","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1111\/echo.14467","volume":"36","author":"J Chen","year":"2019","unstructured":"Chen J, Wang L, Wu FF, Sun G (2019) Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy. Echocardiography (Mount Kisco, NY) 36(9):1682\u20131688. https:\/\/doi.org\/10.1111\/echo.14467","journal-title":"Echocardiography (Mount Kisco, NY)"},{"issue":"2 Pt 1","key":"2103_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jcmg.2017.11.017","volume":"11","author":"E Potter","year":"2018","unstructured":"Potter E, Marwick TH (2018) Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 11(2 Pt 1):260\u2013274. https:\/\/doi.org\/10.1016\/j.jcmg.2017.11.017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2103_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/hco.0000000000000592","volume":"34","author":"G Ong","year":"2019","unstructured":"Ong G, Yan AT, Connelly KA (2019) Clinical application of echocardiographic-derived myocardial strain imaging in subclinical disease: a primer for cardiologists. CurrOpinCardiol 34(2):147\u2013155. https:\/\/doi.org\/10.1097\/hco.0000000000000592","journal-title":"CurrOpinCardiol"},{"issue":"15","key":"2103_CR29","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1093\/eurheartj\/ehl013","volume":"27","author":"TG Neilan","year":"2006","unstructured":"Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES, Ichinose F, Bayne DB, Halpern EF, Weyman AE, Derumeaux G, Bloch KD, Picard MH, Scherrer-Crosbie M (2006) Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 27(15):1868\u20131875. https:\/\/doi.org\/10.1093\/eurheartj\/ehl013","journal-title":"Eur Heart J"},{"issue":"1","key":"2103_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00432-007-0250-9","volume":"134","author":"C Kosmas","year":"2008","unstructured":"Kosmas C, Kallistratos MS, Kopterides P, Syrios J, Skopelitis H, Mylonakis N, Karabelis A, Tsavaris N (2008) Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res ClinOncol 134(1):75\u201382. https:\/\/doi.org\/10.1007\/s00432-007-0250-9","journal-title":"J Cancer Res ClinOncol"},{"issue":"2","key":"2103_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.15420\/icr.2019.12","volume":"14","author":"JH Chong","year":"2019","unstructured":"Chong JH, Ghosh AK (2019) Coronary artery vasospasm induced by 5-fluorouracil: proposed mechanisms, existing management options and future directions. IntervCardiol (London, England) 14(2):89\u201394. https:\/\/doi.org\/10.15420\/icr.2019.12","journal-title":"IntervCardiol (London, England)"},{"issue":"3","key":"2103_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3904\/kjim.2012.27.3.342","volume":"27","author":"SM Kim","year":"2012","unstructured":"Kim SM, Kwak CH, Lee B, Kim SB, Sir JJ, Cho WH, Choi SK (2012) A case of severe coronary spasm associated with 5-fluorouracil chemotherapy. Korean J Intern Med 27(3):342\u2013345. https:\/\/doi.org\/10.3904\/kjim.2012.27.3.342","journal-title":"Korean J Intern Med"},{"issue":"24","key":"2103_CR33","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1161\/circulationaha.107.754424","volume":"118","author":"G Buckberg","year":"2008","unstructured":"Buckberg G, Hoffman JI, Mahajan A, Saleh S, Coghlan C (2008) Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation 118(24):2571\u20132587. https:\/\/doi.org\/10.1161\/circulationaha.107.754424","journal-title":"Circulation"},{"issue":"4","key":"2103_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jcmg.2010.12.007","volume":"4","author":"Y Seo","year":"2011","unstructured":"Seo Y, Ishizu T, Enomoto Y, Sugimori H, Aonuma K (2011) Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging. JACC Cardiovasc Imaging 4(4):358\u2013365. https:\/\/doi.org\/10.1016\/j.jcmg.2010.12.007","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"2103_CR35","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.echo.2011.03.020","volume":"24","author":"SN Li","year":"2011","unstructured":"Li SN, Wong SJ, Cheung YF (2011) Novel area strain based on three-dimensional wall motion analysis for assessment of global left ventricular performance after repair of tetralogy of Fallot. J Am SocEchocardiogr 24(8):819\u2013825. https:\/\/doi.org\/10.1016\/j.echo.2011.03.020","journal-title":"J Am SocEchocardiogr"},{"issue":"5","key":"2103_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.echo.2006.10.013","volume":"20","author":"PP Sengupta","year":"2007","unstructured":"Sengupta PP, Krishnamoorthy VK, Korinek J, Narula J, Vannan MA, Lester SJ, Tajik JA, Seward JB, Khandheria BK, Belohlavek M (2007) Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J Am SocEchocardiogr 20(5):539\u2013551. https:\/\/doi.org\/10.1016\/j.echo.2006.10.013","journal-title":"J Am SocEchocardiogr"},{"issue":"11","key":"2103_CR37","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1586\/14779072.2014.970179","volume":"12","author":"P Pokharel","year":"2014","unstructured":"Pokharel P, Yoon AJ, Bella JN (2014) Noninvasive measurement and clinical relevance of myocardial twist and torsion. Expert Rev CardiovascTher 12(11):1305\u20131315. https:\/\/doi.org\/10.1586\/14779072.2014.970179","journal-title":"Expert Rev CardiovascTher"},{"issue":"8","key":"2103_CR38","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1161\/CIR.0000000000000556","volume":"137","author":"L Mehta","year":"2018","unstructured":"Mehta L, Watson K, Barac A, Beckie T, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Pi\u00f1a I, Volgman A (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137(8):e30\u2013e66","journal-title":"Circulation"},{"issue":"10","key":"2103_CR39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.echo.2004.06.019","volume":"17","author":"M Leitman","year":"2004","unstructured":"Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z (2004) Two-dimensional strain\u2014a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17(10):1021\u20131029. https:\/\/doi.org\/10.1016\/j.echo.2004.06.019","journal-title":"J Am SocEchocardiogr"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-02103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-020-02103-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-02103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T05:29:11Z","timestamp":1723958951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-020-02103-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,27]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-02103-0","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"type":"print","value":"1569-5794"},{"type":"electronic","value":"1573-0743"}],"subject":[],"published":{"date-parts":[[2020,11,27]]},"assertion":[{"value":"7 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study has passed an ethical review and the aapproval number is 2019-124-01. The study has been approved for clinical trial registration with the registration number chiCTR2000035226, and the registration date of 2020.08.04.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}